Free Trial
NASDAQ:CDIO

Cardio Diagnostics 11/13/2023 Earnings Report

Cardio Diagnostics logo
$4.15 -0.40 (-8.79%)
Closing price 03:59 PM Eastern
Extended Trading
$4.14 -0.02 (-0.36%)
As of 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardio Diagnostics EPS Results

Actual EPS
-$5.10
Consensus EPS
-$11.70
Beat/Miss
Beat by +$6.60
One Year Ago EPS
N/A

Cardio Diagnostics Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cardio Diagnostics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Cardio Diagnostics' next earnings date is estimated for Wednesday, November 12, 2025, based on past reporting schedules.

Conference Call Resources

Cardio Diagnostics Earnings Headlines

Bezos to unlock “Holy Grail of Power”
It's no secret that artificial intelligence is gobbling up energy at an unprecedented rate... straining America's already vulnerable power grid. All the big players are racing to find a new way to meet AI's power-hungry daily demands, pouring in billions of dollars for alternative energy sources. Amazon (AMZN) may have just cracked the code.tc pixel
Cardio Diagnostics Holdings, Inc. (CDIOW) - Yahoo Finance
See More Cardio Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cardio Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardio Diagnostics and other key companies, straight to your email.

About Cardio Diagnostics

Cardio Diagnostics (NASDAQ:CDIO) develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

View Cardio Diagnostics Profile

More Earnings Resources from MarketBeat